SUMMARY Serum concentrations of fucose, sialic acid, and eight acute phase proteins were measured in single specimens from patients with cancer in order to determine whether the raised concentrations of protein bound sugars commonly found in cancer correlate with increased concentrations of the acute phase proteins. Strong positive correlations were found only with a,-acid glycoprotein, ai-antitrypsin, and haptoglobins. Changes in protein bound sugars and acute phase proteins were also examined in relation to patients' disease states. Serum fucose was raised more often in patients with advanced disease than in those in whom the spread of the tumour was more restricted; increased sialic acid concentrations, however, were found with a similar frequency in both these groups. Combined use of fucose and sialic acid values gave a high degree of marker positivity which could be only slightly improved on . The latter were either in hospital or attending outpatient clinics. Some were already receiving treatment and others had yet to start. Serum was separated by centrifugation and stored at -20°C until required for assay.
acute phase proteins were also examined in relation to patients' disease states. Serum fucose was raised more often in patients with advanced disease than in those in whom the spread of the tumour was more restricted; increased sialic acid concentrations, however, were found with a similar frequency in both these groups. Combined use of fucose and sialic acid values gave a high degree of marker positivity which could be only slightly improved on by including measurement of acute phase proteins. The combined use of serum fucose and sialic acid concentrations may have value in monitoring patients with cancer: the sialic acid provides an index of the acute phase response and the fucose a measure of the tumour spread.
Serum fucose' 2and sialic acid34 concentrations are often increased in patients with cancer, but there is no satisfactory explanation for these changes. There are many possibilities: increased glycosylation of serum glycoproteins; shedding of glycoproteins from the tumour cell surface; and increased concentrations of normal serum glycoproteins. The object of this study was . The latter were either in hospital or attending outpatient clinics. Some were already receiving treatment and others had yet to start. Serum was separated by centrifugation and stored at -20°C until required for assay. mens were chosen at random. rected using serum blanks in which the proteins Serum fucose concentrations were measured were unhydrolysed. The sialic acid content of serum using a fucose dehydrogenase method similar to that was determined using a periodate/thiobarbituric described elsewhere.7 Briefly, 0-1 ml of serum was acid method.8 Before assay the protein bound sialic incubated with 0-9 ml of 0d155 mol/l H2so4 at 100°C acid was released by hydrolysing 50 ,ul of serum in for 1 h. The acidified serum was neutralised with 2 ml of 005 mol/1 H2so4 at 80°C for 1 h. No free saturated barium hydroxide to a total volume of sialic acid was detected in unhydrolysed sera, and all 18 ml; 02 ml of this supernatant was added to specimens were corrected for deoxyribose contami- Values given in parentheses indicate the number of sera assayed. Reference values for fucose, sialic acid, and acute phrase proteins are based on 270, 261, and 37 estimations respectively. *Upper 95% confidence limit. tPercent raised above the given confidence limit.
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nation. Serum concentrations of fucose and sialic acid are expressed as mg/g serum protein.
Protein was determined by the biuret method.9 The serum protein concentrations for the healthy and cancer groups were 68-6g/l (SD 4-8g/l; n = 269) and 65-0g/l (SD 7-8g/l; n = 182) respectively.
Acute phase protein concentrations were estimated by radial immunodiffusion (Partigen Plates, Hoechst Pharmaceuticals). Standards were obtained from Hoechst and the results were expressed as g/l. The interassay coefficients of variation for the fucose, sialic acid, and acute phase protein assays were about 10%, 8%, and 5% respectively. Table 3 shows the correlations between the concentration of fucose or sialic acid and the concentrations of the different acute phase proteins in individual patients with cancer. The data fall into three groups: one group (al-acid glycoprotein, a,-groups; one group (al-acid glycoprotein, ac, antitrypsin, haptoglobins) in which the association is strongly positive; another group (prealbumin, transferrin), in which the association is strongly negative; and a third group (caeruloplasmin, haemopexin, a2-macroglobulin), in which the association is much weaker. Measurements on healthy serum samples did not indicate any strong correlations except in the case of haemopexin, which appeared to correlate strongly with both sugars (data not given). Table 4 shows the degree of increase of the protein bound sugar in the patients with cancer according to patients' disease states. The number of patients in each subgroup with raised fucose concentrations increases with tumour progression, with a 70% increase in those with more advanced disease. On the other hand, the number of patients Relation between raised concentrations offucose, sialic acid, and acute phase proteins in serum When the sugar data were classified according to patients' disease states we obtained further support for the idea that serum fucose and sialic acid are increased by different mechanisms. Not only were the patterns of increase for the two sugars different, but also for patients in whom the involvement of the tumour was limited either naturally or by treatment, the increase in fucose concentration often complemented the increase in sialic acid. The combined use of these two markers gave a high degree of positivity that could only be slightly improved on by including the acute phase protein measurements. To the best of our knowledge, the combined use of fucose and sialic acid for monitoring the effects of treatment has not been previously reported. Our results indicate that further investigations are necessary to assess the full potential of this approach.
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